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1. Introduction
According to theWHO deﬁnition, “Palliative care is an approach that
improves thequality of life of patients and their families facing the prob-
lems associated with life-threatening illness, through the prevention
and relief of suffering by means of early identiﬁcation and treatment
of other problems, physical, psychosocial and spiritual” [1]. In addition,
“Palliative care is required from early in the disease course, can be deliv-
ered alongside potentially curative treatment, and continues to include
end-of-life or terminal care” [2].
The WHO deﬁnition highlights fundamental principles. It “afﬁrms
life and regards dying as a normal process”; and “intends neither to has-
ten nor postpone death” [1]. It also emphasizes “impeccable assess-
ment” as essential for effective management.
Palliative care cannot be left solely to primary or palliative care physi-
cians or to nurses. It needs to be actively embracedby all providers includ-
ing oncologists and other specialists and integrated into all areas of
medical care [3,4]. Oncology follow-up visits are the ideal place to intro-
duce the concept and every decision about treatment should take pallia-
tive or quality of life considerations into account. Giving up curative
treatment does notmean giving up hope or concern, nor does an attempt
at curative treatment mean that palliative care should not be offered.
Discussions about end-of-life care, refusal of care, and advance planning
have cultural dimensions that require great sensitivity and thought, but
opening these discussions is critical to the best end-of-life care [5].
Palliative care is an approach that embodies compassion [6]. It is not
dependent on sophisticated equipment, expensive buildings, or tech-
nology, and can be applied in any setting. It can easily be offered in
resource-poor settings as well as in countries with highly developed
healthcare services.
In practice this depends on a signiﬁcant shift in focus.Many societies
avoid and fear aging, death, and dying. Huge advances inmedicine have
fed the belief that medicine can rescue everyone. Medicine has a re-
sponsibility to explore and address these fears as well as embrace and
advocate for the best of palliative care.
Some 80% of countries globally have low or very restricted access to
strong pain medications [7]. Although morphine is the gold standard
and the cheapest drug available, it is still illegal or unavailable in many
countries [7]. The African Palliative Care Association and others are
working actively to change this [8].
In addition to end-of-life issues, gynecological cancer presents many
long-term problems related to disease and treatment [9]. Both aspects
require a palliative focus.
2. Therapeutic relationship: The cornerstone of care
People have a deep need to be seen and heard. This in itself is ther-
apeutic. Very often it is notwhatwas said but how it was said that is re-
membered. Good communication depends on sensitivity, authenticity,
and genuine human relationship [10]. Healthcare providers need to
convey that they care and that theywill be there for their patientswhat-
ever path they take. Patients can fear being abandoned if cure is no lon-
ger a possibility, and providing the security of a continuing relationship
with their trusted caregiver is a key component.
Dealing with death and dying requires us to constantly confront our
own fears. Physicians can struggle to overcome not only their teaching,
which emphasizes rescuing and curing, but also their own fear of dis-
ability and dying. Caring for the dying invites us to look at our own
lives, values, attitudes, and beliefs to care compassionately for the
scope of needs our patients encounter on their cancer journey.
3. Ethical Issues
Ethical issues relate to both patients and context of care. Our
primary ethical responsibilities are to beneﬁt (beneﬁcence) and not
harm (non-maleﬁcence) while making sure patients understand and
can choose among options for their care (autonomy). In palliative care
the treatment goals are primarily ameliorating symptoms, alleviating
pain and suffering, and helping patients understand the disease course.
These become our ethical measures for success. Care of symptoms and
attention to quality of life are goals regardless of the curability of the
cancer [11], and have been shown to improve quality of life and
mood, and even lengthened survival in some studies [11].
Preserving patient autonomy—the ability to make authentic deci-
sions regarding their own health care—is essential, though often
difﬁcult. Societal, religious, and familial pressures on patients and care-
givers have the potential to overwhelm decision making. The classic
example of family demanding “everything” be done to save their
mother, while the mother wants to have no resuscitative measures
with her terminal disease illustrates how this tension can present.
Women are at the center of families and oftenmake choices that beneﬁt
the family before themselves—denying themselves adequate pain or
other care because of cost or inconvenience to the family. Our role is
to advocate for the patient’s best interests, including encouragement
to ask for what she wants and needs.
Globally, lack of access to adequate pain control, palliative care op-
tions such as radiation, or advanced pain control techniques create
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ethical challenges related to context of care. Regulations that limit ac-
cess to narcotic pain management at the end of life are harmful to
patients. Providers must advocate actively for policies and just alloca-
tion of essential medication and palliative care support in every re-
source setting [12].
4. Interdisciplinary team work
Palliative care emphasizes whole person medicine and it is impossi-
ble for one person to do this alone. Effective palliative care depends on
good teamwork. As an ideal, the basic care team should consist of a doc-
tor, professional nurse, and social worker. The team can beneﬁt from a
dietician, occupational therapist, physiotherapist, massage therapist,
and creative artists, as well as a “gynecologic oncologist, a radiation on-
cologist, a radiologist, an interventional radiologist, a pain specialist
from hospice services, and/or a palliative care physician” [13]. In many
settings this is not possible—but engaging cross-disciplinary health
providers provides different perspectives, ideas, and approaches that
can beneﬁt patient care. Incorporating spiritual care into the team
helps address not only the patient’s but their family’s and even the
team’s need to ﬁnd meaning in the process of care and dying and
transcend suffering.
Constant exposure to death and dying can rapidly lead to provider
burnout unless the load is shared. Teamwork can be challenging and re-
quires good leadership and constant review.Well implemented it great-
ly improves quality of care, stress, and work satisfaction. Poor team
work can contribute to burnout. Five essentials are: trust, two-way
communication, respect, roles, and responsibility. Additional qualities
of good team work include positive leadership and management;
personal rewards, training, and development; skill mix; supportive
team; clarity of vision; and respecting and understanding roles [14].
5. Pain control
“As with most incurable cancers, pain control is the dominant issue
and must be addressed. Judicious use of narcotics, radiation, and
nonnarcotic pain remedies is essential” [12].
The goal of pain control needs to be discussed. For example: is the
goal to preserve normal function and ability to work—and what is re-
quired for that? Is it to provide relief from neuropathic pain? Each situ-
ation requires a unique approach that will often be multimodal [15].
Understanding pain type, acuity, inciting and diminishing factors is
key to pain management. Prior drug interactions and physical, mental,
and contextual status should all be reviewed initially and on an ongoing
basis (Table 1).
The axiom of pain control is to treat different types of pain different-
ly. Pain from cerebral swelling with brain metastases includes cortico-
steroids to reduce swelling and enhance function, as well as analgesic
medications. Pain from abdominal swelling can beneﬁt from massage
for back strain (due to abnormal posture), abdominal massage, or heat
as well as analgesia. Neuropathic pain may require early medication,
massage, and physical therapy to improve function. Treatment of
anxiety may reduce the need for analgesics.
When medication is required, theWHO pain ladder [16,17] remains
the standard,with non-narcotic therapies at its base. If themanagement
plan is not meeting pain needs, then reassessment of all elements is
required—before adding narcotic medications. Successful pain control
depends on around the clock base relief, together with rapid acting
breakthrough medication for intermittent increases in pain or desire
to increase activity (Table 2). Finally, it is important to anticipate, assess,
and manage any adverse effects of medication, in particular, constipa-
tion, nausea, and vomiting
In places without access to narcotic medications, pain management
(particularly for end-of-life care or acute cancer pain) is exceptionally
difﬁcult and a tragedy for the patient and her family. Maximal use of
all available medication, liberal use of additional means of comfort
(massage, heat, physical therapy, positioning), as well as ongoing advo-
cacy for rational narcotic access to prevent suffering, become essential
parts of treatment [18].
6. Other symptoms
Each disease has its own unique picture. Symptoms may be disease
or treatment related. “Treatment…often has serious lifelong side
effects, including cystitis, proctitis, intestinal strictures, ﬁstulas, vaginal
agglutination/sexual dysfunction, and chronic pain” [9].
Table 1
Key elements to review in planning a pain management strategy.
Elements to consider
What is the goal of pain management? Functional level, desired sensory levels,
time speciﬁc goals such as a speciﬁc event.
Priority among goals
What is the type of pain? Neuropathic, tissue damage, pressure,
musculoskeletal, inﬂammatory
Duration, level, and modifying factors Constant, occasional, related to
movement, morning, evening, etc. Use a
scale to measure level of pain
Prior management programs that
have been effective
Heat, cool, massage, physical therapy,
types of pain medicines
Reactions to pain or psychotropic
medicines
Allergies, nausea, constipation, depression,
other adverse effects
Overall health that may impact
choices for pain management
Depression, anxiety, or other psychiatric
conditions; addictions; renal and hepatic
function; cenral nervous system function;
respiratory distress; physical performance
status; nutritional status; skin status
Contextual modiﬁers Lack of insurance, ﬁnances, or limitations;
religious beliefs regarding suffering; lack
of care givers; safety of home setting
Table 2
Elements of a cancer pain strategy.
Strategy
Treat different types of pain differently.
Use multimodal approach and
combine as needed.
Neuropathic pain: anticonvulsants,
antidepressants, gabapentinoids,
transcutaneous stimulation.
Acute inﬂammation: corticosteroids.
Anxiety and depression: anxiolytics and
antidepressants.
Tissue damage pain (nociceptive): scale of
anti-inﬂammatory to narcotic medications.
Bone metastases/brain metastases:
consider local radiation therapy.
If available, for localized pain, blocks and
indwelling epidural analgesia.
Give the medication at regular intervals Provide a base level of pain control and
accommodate for breakthrough pain.
Use the least invasive form of
administration available
Oral, topical (patches and creams),
sublingual forms preferred over
subcutaneous or intravenous forms.
Adjust to comfort and individual goals The patient is the best judge of whether
pain control is meeting her goals, and
individual tolerance and needs vary widely
Make liberal use of additional
supportive care
Consider the role that massage, heat,
meditation, physical therapy, positioning,
and alternative therapies (aromatherapy,
music therapy, etc.) and spiritual care can
play to assist pain and anxiety control.
Anticipate adverse effects and plan
for them
Constipation, somnolence, nausea can all
accompany pain control and planning
ahead can improve outcomes.
Anticipate changes in needs Use a pain scale and follow over time, as
needs will change both up and down with
treatment or progression of disease
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General management principles [19] are:
• Appropriate assessment
• Explanation to patient and family at all stages
• Correct reversible factors
• Consider disease-speciﬁc palliative therapy
• Non-pharmacological interventions
• Appropriate ﬁrst line treatment
• Adjuvant or second line treatment
• Regular review with involvement of the interdisciplinary team…or
more experienced clinician; plus
• Essential medication in palliative care (Table 3).
6.1. Loss of appetite and fatigue
Eating is a fundamental human experience and feeding people is a
natural way of showing care and support. Many family members strug-
gle to accept that the patient no longer wants to eat and this causes sig-
niﬁcant distress. If aiding the appetite will improve the patient’s quality
of life or the patient has speciﬁc short-term goals, then progestins or
steroids to stimulate appetite may be considered.
6.2. Edema and ascites
Edema is common in late-stage gynecologic cancers owing to low
protein and lymphatic blockage, and is difﬁcult to treat. Regular lymph
drainage massage and limb wrapping or support stockings/sleeves
may assist comfort.
Ascites may require repeated drainage or an indwelling catheter, al-
though this must be balanced against the additional loss of protein and
increase in edema that result. High-dose spironolactone (100–400 mg
per day) with furosemide may improve ascites.
6.3. Nausea and vomiting
Common causes are mechanical bowel obstruction, infection, meta-
bolic disturbance (including hypercalcemia), renal failure, and occa-
sionally cerebral metastases [9].
Bowel obstruction is a frequent occurrence, especially with ovarian
cancer, but few patients are amenable to surgical intervention and
must be chosen carefully after balancing patient preference, likelihood
of surgical success, prognosis, and risk factors. A simple colostomy
with progressive pelvic cervical cancer may give relief quickly without
a long surgical recovery time. Given the multiple sites of obstruction,
particularly with progressive ovarian cancer, surgery is rarely used.
Nasogastric tubes are discouraged because they are uncomfortable,
but nasogastric or percutaneous gastric tubes may be helpful when
other approaches are not helping [20]. Antiemetics and medications to
reduce intestinal output are available for subcutaneous, rectal, oral/
lingual, and intravenous use, and continuous or around-the-clock use
is the most effective approach.
Often people cannot tolerate the idea of not being able to eat. Even
in the presence of total gastric outlet obstruction, many patients prefer
to eat a little and are prepared to tolerate vomiting rather than stop
eating completely.
6.4. Constipation, diarrhea, fecal incontinence
Constipation, whether disease or medication induced, is a major
cause of discomfort and suffering. Pain medication may complicate
management, and a laxative regimen should always be provided along
with these medications, assuming there is no obstruction. Regular as-
sessment and repeated education sessions are necessary.
Diarrhea may be a short- or long-term consequence of treatment,
and treatment should be focused on the etiology. For example, simple
lactose intolerance after radiation or long-term narcotic-based regi-
mens to repress bowel motility have different solutions.
Fecal incontinence has a major impact on quality of life, and bowel
regimens or rarely surgical diversion can help. For the most part, local
attention to hygiene and skincare provides the best palliation for this
symptom from surgery, ﬁstulas, or disease.
6.5. Incontinence, urinary retention, urinary tract infection
Urinary incontinence may result from spinal cord compression, sa-
cral plexus involvement, bladder inﬁltration, or ﬁstulas. Skin protection
using barrier creams is essential. Urinary catheters, suprapubic catheter,
or nephrostomy are considerations. Each of these comeswith increasing
complexity of management for the patient and caregivers and may
be unaffordable.
Urinary tract infection is common, with or without catheterization
and should be actively checked and treated.
6.6. Vaginal discharge and bleeding
Evaluation of a new discharge is always warranted as it may repre-
sent fungal or bladder infection, which can be treated. Discharge from
tumor growth, bleeding, or ﬁstula is very upsetting to the patient and
her caregivers. Collaboratively developing a plan for hygiene and pro-
viding a sense of control, particularly with vaginal bleeding, facilitates
management and opens the door to further discuss progression of dis-
ease and expectations.
Minor bleeding wounds may respond to topical adrenaline.
Cyklokapron (tranexamic acid), radiotherapy, or occasionally interven-
tional radiology-based embolization, if available, may be useful to stop
bleeding. Direct pressure may also assist, for example a vaginal pack
and use of Monsel solution or other topical agents for cervical cancer
bleeding. Symptomatic anemia can be treated with blood transfusion
if resources allow and if the beneﬁts in terms of symptom relief and
quality of life are of reasonable and ethical duration.
Hemorrhage as the ﬁnal event is one that can traumatize all who
witness it. In patients where this is a possibility, family members and
healthcare providers should be prepared.
6.7. Shortness of breath
Air hunger and shortness of breath may result from anemia, infec-
tion, pleural effusion, lung metastases, or heart failure. Diuretics are
Table 3
Essential medication for palliative care.a
Requirement Use Medication
Pain General Paracetamol, tramadol, codeine,
morphine (aWHO essential medicine),
fentanyl.
Bone pain Ibuprofen, indomethacin.
Neuropathic pain Gabapentin (neuropathic pain).
Neuro-psychiatric Anxiety Lorazepam, diazepam.
Insomnia/restlessness Zolpidem, midazolam, haloperidol.
Depression Amitriptyline, citalopram.
Gastrointestinal Constipation Laxatives (senna, liquid parafﬁn,
glycerin and dulcolax suppositories,
ﬂeet enema).
Diarrhea Immodium, codeine.
Nausea/vomiting Metoclopramide, hyoscine
butylbromide, haloperidol, 5-HT3
antagonists, steroids, proton pump
inhibitors
Other Inﬂammation Dexamethasone, prednisolone.
Fluid/ascites Spironolactone, furosemide.
Bleeding Adrenalin, cyklokapron.
a For more details see the IAHPC List of Essential Medicines for Palliative Care [22].
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seldom helpful except in heart failure. Fanning, morphine, and oxygen
bring symptomatic relief, as does anxiety control.
Pleural drainage and pleurodesis may be helpful for comfort and to
prevent recurrence of a pleural effusion if the condition of the patient
warrants this.
6.8. Deep vein thrombosis
Prevention is preferredwith passive or activemovement. Sequential
compression devices and anticoagulant therapy need to be considered
in the context of the patient’s prognosis, quality of life, and living
conditions, and balanced against the risk of bleeding.
6.9. Psycho-spiritual
Anxiety, depression, fear, denial, loss of body image, sexual frustra-
tion, and insomnia are almost always present to some degree and can
signiﬁcantly impact on physical symptoms. Treatment approaches are
both pharmacological and non-pharmacological.
Gynecological cancer strikes deep to the core of what it means to be
a woman. It is hidden, private, deep-seated, andmay be associated with
deep shame. Additionally, women try to avoid causing distress to their
families and one of the greatest challenges to their identity can come
from being the one needing care rather than being the care giver.
Great sensitivity is needed in handling these women.
Existential fear in the face of death cannot be avoided and is part of
the human condition, but the more open the discussion and the more
active the personal support, the more ease the patient may feel in the
transition. Denial may need to be more actively confronted when it in-
terferes with proactive planning for future care of the patient or minors.
Spiritual support, essential and integral to holistic care, must be indi-
vidualized according to the patient’s religion, culture, and belief system.
It cannot be imposed or directed by the caregiver’s views.
7. Social considerations
Detailed social assessment of needs, preferably with a social worker
is imperative. Particular attention should be given to ﬁnancial needs,
needs of children, care, legal issues andwills, unresolved family conﬂict,
and future planning. Social problems are often the main cause of
anxiety. Sometimes simple assistance, like a letter to an employer, is
all that is needed.
8. Palliative care emergencies
Detailed discussion is beyond the scope of this article and can be
found in the references [21]. Extremely rapid treatment is needed in
the case of hemorrhage, hypercalcemia, superior vena cava syndrome,
and spinal cord compression, butwemust still weigh the potential ben-
eﬁts and harms particularly with patients for whom survival is already
expected to be short.
9. Pressure and wound care
Good care can prevent skin pressure ulcers. The sacrum and heels
are vulnerable areas in bed-bound patients and need frequent evalua-
tion. Simple movement on a regular basis will assure pressure relief
and enable local circulation. Sheepskin or other “boots” and pads also
improve circulation.
Wound healing can be assisted by multiple means. Keeping wounds
clean and dry is the basis of care. Continuous vacuum dressings have
signiﬁcantly improved time to wound closure for open wounds and
may also be helpful in managing discharge frommalignant skin lesions
(cutaneous metastases) where no further therapy is planned.
10. End-of-life care
Cultural, religious, and spiritual views determine how patient and
family view the information that death is approaching. Good timing
and sensitivity are imperative. Each family unit is unique and there
are no blanket rules but clear, honest, compassionate communication
is needed. People vary in how much they need and want to know.
Usually the patient knows what is happening and may or may not
want more information. Generally family members welcome honest
communication and frequent updates are vital. Even in the late stages,
include the patient in the discussion and do not assume that lowered
level of consciousness means lack of awareness or feeling.
Comfort is the major factor determining treatment decisions.
Physical and psycho-spiritual needs must be assessed regularly and
unnecessary medication and intervention discontinued. Common end-
of-life symptoms are pain, nausea, vomiting, agitation, and respiratory
difﬁculty.When oralmedication is no longer possible, sublingual, rectal,
and subcutaneous administration are options. A restless patient may
have urinary retention, which can be relieved. Impeccable and gentle
nursing care is imperative with special attention to turning, wet linen,
diapers, bowel, skin, and mouth care.
Grief is expressed in myriad ways, some of which can be disturbing
to the patient or others around her. Challenges can arise when religious
or cultural taboos forbid the discussion of death as a possibility, let alone
a probability. Somegroups see it as a sin to give up hope or even to think
“negatively.” These beliefs can present major challenges to appropriate
planning and management. Wherever possible provide information
about the dying process, what to do in the event of death and the avail-
ability of bereavement support.
11. Conclusion
If the principles of palliative care are understood they can be inte-
grated into all levels of health care and all levels of healthcare training.
The principles are not complicated and once the concept is embraced,
shifting focus from curative to palliative should ideally become as sim-
ple as watching the sun rise and the sun set. Palliative care requires
both the art and science of medicine and is a pressing universal need.
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